Clonidine Hydrochloride
Generic Name: clonidine hydrochloride
Brand Names:
Clonidine Hydrochloride
Clonidine hydrochloride is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and 0.3 mg.
Overview
Clonidine hydrochloride is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and 0.3 mg.
Uses
Clonidine hydrochloride tablets USP are indicated in the treatment of hypertension. Clonidine hydrochloride tablets USP may be employed alone or concomitantly with other antihypertensive agents.
Dosage
The dose of clonidine hydrochloride tablets must be adjusted according to the patient's individual blood pressure response. Initial Dose 0.1 mg tablet twice daily (morning and bedtime).
Side Effects
Most adverse effects are mild and tend to diminish with continued therapy. The most frequent (which appear to be dose-related) are dry mouth, occurring in about 40 of 100 patients; drowsiness, about 33 in 100.
Interactions
Clonidine may potentiate the CNS-depressive effects of alcohol, barbiturates or other sedating drugs.
Warnings
Patients should be instructed not to discontinue therapy without consulting their physician. Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, and tremor. Contraindicated in patients with known hypersensitivity to clonidine.
Storage
Store at 20 to 25 degrees C (68 to 77 degrees F).
Frequently Asked Questions
What is Clonidine Hydrochloride used for?▼
Clonidine hydrochloride tablets USP are indicated in the treatment of hypertension. Clonidine hydrochloride tablets USP may be employed alone or concomitantly with other antihypertensive agents.
What are the side effects of Clonidine Hydrochloride?▼
Most adverse effects are mild and tend to diminish with continued therapy. The most frequent (which appear to be dose-related) are dry mouth, occurring in about 40 of 100 patients; drowsiness, about 33 in 100.
What are the important warnings for Clonidine Hydrochloride?▼
Patients should be instructed not to discontinue therapy without consulting their physician. Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, and tremor. Contraindicated in patients with known hypersensitivity to clonidine.
Related Medications
Talquetamab
talquetamab
11 DESCRIPTION Talquetamab-tgvs is a bispecific GPRC5D-directed CD3 T-cell engager. It is a humanized IgG4 proline, alanine, alanine (IgG4-PAA)-based bispecific antibody produced by Chinese hamster ovary (CHO) cells using recombinant DNA technology. Talquetamab-tgvs consists of an anti-GPRC5D heavy chain and light chain and an anti-CD3 heavy chain and light chain with two interchain disulfide bonds connecting the two arms. The molecular weight of talquetamab-tgvs is 147 kDa.
Peach Prunus Persica
peach prunus persica
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: PEACH (.1 g/mL). Category: BLA.
Glycolic Acid, Citric Acid, Lactic Acid, Kojic Acid
glycolic acid, citric acid, lactic acid, kojic acid
Resorcinol peel purpose
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.